Issues surrounding drug effectiveness and regulation are being debated, involving the FDA, WHO, and political figures like Marjorie Taylor Greene and Robert F. Kennedy Jr. in Tennessee.
Steady: 0 in the last 7 days
Updated sep 24
The latest in this situation
- Trump proposes dose splitting despite WHO review, while Kennedy and McCullough challenge vaccine safety and ingredients.
- Bloomberg reported on Robert F. Kennedy Jr.'s group, noting that OpenAI sponsored a summit linked to his work, as he criticizes corporate influence in health agencies.
- The intersection of corporate payments, regulatory bodies like the FDA, and the influence of companies like OpenAI on official agendas are being scrutinized.
- The FDA and FCC are facing lawsuits regarding the dismissal of evidence, alongside commissioning a review into potential risks posed by cell phones.
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Issues surrounding drug effectiveness and regulation are being debated, involving the FDA, WHO, and political figures like Marjorie Taylor Greene and Robert F. Kennedy Jr. in Tennessee.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Trump proposes dose splitting despite WHO review, while Kennedy and McCullough challenge vaccine safety and ingredients.Sub-event
- The intersection of corporate payments, regulatory bodies like the FDA, and the influence of companies like OpenAI on official agendas are being scrutinized.Sub-event
- The FDA and FCC are facing lawsuits regarding the dismissal of evidence, alongside commissioning a review into potential risks posed by cell phones.Sub-event
- Gallup and West Health are tracking healthcare affordability trends, noting high U.S. costs and seeking stem cell therapy in Mexico.Sub-event
Debate over drug effectiveness and health misinformation heats up, involving FDA oversight and political figures.1 source
Keep exploring
The entities involved
- FDA
-
Tennessee
state of the United States of America
-
World Health Organization
United Nations agency concerned with international public health
-
Marjorie Taylor Greene
American politician
Related events
- FDA hosts a public meeting at White Oak as it begins rethinking drug development under Donald Trump's influence.
- Marty Makary serves as FDA Commissioner overseeing drug approvals and advocates for psychedelic therapies in clinical settings.
- Congress and the Senate are considering legislation affecting FDA submissions and drug patent rights.